✦ LIBER ✦

Neoadjuvant docetaxel (DOC 75) followed by fluorouracil, epirubicin, cyclophosphamide (FEC 100) in primary operable breast cancer: results of a multicenter phase II trial

✍ Scribed by N. Sato; H. Iwata; N. Masuda; S. Nakamura; N. Yamamoto; K. Kuroi; M. Kurosumi; H. Tsuda; F. Akiyama; M. Toi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of pathological response of m

✍ S. Nakamura; Toi; Y. Takatsuka; K. Kuroi; H. Iwata; S. Ohno; N. Masuda; H. Tsuda 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 136 KB

0142 Feasibility study of fluorouracil/e

✍ Y. Rai; M. Tanaka; M. Mitsuyama; T. Uga; S. Tanaka; K. Nanba; H. Furusawa; K. Mu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 54 KB

A Phase II Neoadjuvant Trial of Sequenti

✍ André Robidoux; Aman U. Buzdar; Emmanuel Quinaux; Samuel Jacobs; Priya Rastogi; 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 122 KB

Fluorouracil, epirubicin, and cyclophosp

✍ Buzdar, Aman U; Suman, Vera J; Meric-Bernstam, Funda; Leitch, A Marilyn; Ellis, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 178 KB

A phase III adjuvant randomised trial of

✍ Delbaldo, C.; Serin, D.; Mousseau, M.; Greget, S.; Audhuy, B.; Priou, F.; Berdah 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 761 KB

0178 Results of clinical endpoints of a

✍ A. Schneeweiss; A. Ruiz; P. Rovira; A. Bottini; A. Manikhas; J. Wacker; T. Schum 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 54 KB